moxifloxacin
Showing 1 - 25 of 267
Obesity Trial in Berlin (Cagrilintide, Cagrilintide Placebo, Moxifloxacin)
Not yet recruiting
- Obesity
- Cagrilintide
- +3 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Mar 27, 2023
Healthy Trial in Overland Park (Rodatristat Ethyl, Moxifloxacin, Placebo for Rodatristat)
Recruiting
- Healthy
- Rodatristat Ethyl
- +3 more
-
Overland Park, KansasAltasciences Clinical Kansas, Inc.
Jul 5, 2023
Healthy Trial (BI 1015550, Moxifloxacin, Placebo)
Not yet recruiting
- Healthy
- BI 1015550
- +2 more
- (no location specified)
Nov 2, 2023
Endophthalmitis Trial in Saint George (Moxifloxacin, Placebo)
Not yet recruiting
- Endophthalmitis
- Moxifloxacin
- Placebo
-
Saint George, UtahZion Eye Institute
Dec 31, 2022
Health Adult Subjects Trial (Omaveloxolone, Moxifloxacin)
Not yet recruiting
- Health Adult Subjects
- Omaveloxolone
- Moxifloxacin
- (no location specified)
Jun 28, 2023
Non-alcoholic Steatohepatitis Trial in Berlin (Cotadutide, Cotadutide-, Moxifloxacin)
Recruiting
- Non-alcoholic Steatohepatitis
- Cotadutide
- +3 more
-
Berlin, GermanyResearch Site
Jan 16, 2023
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes, Healthy Volunteers Trial in Neu-Ulm
Not yet recruiting
- Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
- +2 more
- Moxifloxacin
- +2 more
-
Neu-Ulm, Bayern, GermanyNUVISAN GmbH
Jul 28, 2022
Drug-induced QT Prolongation, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Clarithromycin, Pimozide, Placebo (Part 1))
Not yet recruiting
- Drug-induced QT Prolongation
- +2 more
- Clarithromycin
- +6 more
-
West Bend, WisconsinSpaulding Clinical Research
Feb 7, 2023
Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)
Recruiting
- Pulmonary Tuberculosis
- Other Specified Pulmonary Tuberculosis
- Sutezolid
- +6 more
-
Lambaréné, Gabon
- +7 more
Apr 17, 2023
Healthy Trial in New Haven (sisunatovir, , moxifloxacin)
Recruiting
- Healthy
- sisunatovir
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
May 18, 2023
Healthy Volunteer Study Trial in Québec (Bemnifosbuvir (BEM), Placebo, Moxifloxacin)
Completed
- Healthy Volunteer Study
- Bemnifosbuvir (BEM)
- +2 more
-
Québec, Montreal, Quebec, CanadaAtea Study Site
Jun 14, 2023
Healthy Volunteers Trial in Tempe (Epetraborole and matching , Epetraborole, Placebo)
Active, not recruiting
- Healthy Volunteers
- Epetraborole and matching placebo
- +3 more
-
Tempe, Arizona423001
Aug 16, 2023
QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)
Recruiting
- QT/QTc
- Ecopipam Hydrochloride
- +2 more
-
Austin, TexasPPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023
Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,
Not yet recruiting
- Tuberculosis, Pulmonary
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +3 more
Jun 22, 2023
Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Toshima-ku, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022